Lei Wu

5.7k total citations · 1 hit paper
171 papers, 4.3k citations indexed

About

Lei Wu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Lei Wu has authored 171 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 107 papers in Molecular Biology, 57 papers in Cancer Research and 36 papers in Oncology. Recurrent topics in Lei Wu's work include Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (24 papers) and MicroRNA in disease regulation (19 papers). Lei Wu is often cited by papers focused on Cancer-related molecular mechanisms research (37 papers), RNA modifications and cancer (24 papers) and MicroRNA in disease regulation (19 papers). Lei Wu collaborates with scholars based in China, United States and Bangladesh. Lei Wu's co-authors include Zhi‐Jun Sun, Wen‐Feng Zhang, Guang‐Tao Yu, Liang Mao, Lin‐Lin Bu, Wei‐Wei Deng, Lili Yang, Leilei Yang, Cong‐Fa Huang and Yicun Li and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Lei Wu

158 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis

2020 307 citations Lang Rao, Lei Wu et al. Nature Communications profile →

Peers

Lei Wu

MB

CR

IMMUN

ONCOL

BE

Junnian Zheng China

Wei Qiu China

Helmut Dolznig Austria

Yi Zhu China

Liping Sun China

Chuan‐Yuan Li United States

Xi Chen China

Anping Li China

Minghui Wang China

Xing Huang China

Junnian Zheng China

Lei Wu

3.6k ×1.5

MB

1.7k ×1.3

CR

1.2k ×1.0

IMMUN

1.9k ×1.7

ONCOL

367 ×0.8

BE

Citations per year, relative to Lei Wu Lei Wu (= 1×) peers Junnian Zheng

Countries citing papers authored by Lei Wu

Since Specialization

Citations

This map shows the geographic impact of Lei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Wu more than expected).

Fields of papers citing papers by Lei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Wu. The network helps show where Lei Wu may publish in the future.

Co-authorship network of co-authors of Lei Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Wu. A scholar is included among the top collaborators of Lei Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Wu. Lei Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Wu, Lei, et al.. (2025). ICG Fluorescence Cholangiography in Laparoscopic Transductal Common Bile Duct Exploration in Patients With Previous Upper Abdominal Surgery: A Propensity Score-matched Analysis. The American Surgeon. 92(2). 500–508.

2.

Wu, Lei, et al.. (2025). Targeting lipid metabolism to enhance cancer immunotherapy. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer. 1880(5). 189416–189416.

3.

Zhang, Lulu, et al.. (2025). Observation on the Effect of Transconjunctival Lower Blepharoplasty Combined With Orbital Fat Release in Middle‐Aged and Elderly Men. Journal of Cosmetic Dermatology. 24(5). e70054–e70054.

4.

Zhu, Xiang, Pin Zhang, Han Jiang, Jie Kuang, & Lei Wu. (2024). Using the Super Learner algorithm to predict risk of major adverse cardiovascular events after percutaneous coronary intervention in patients with myocardial infarction. BMC Medical Research Methodology. 24(1). 59–59. 4 indexed citations

5.

Song, An, Lei Wu, Boxin Zhang, et al.. (2024). Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma. Cancer Letters. 588. 216727–216727. 16 indexed citations

6.

Wu, Lei, Yongpeng Li, Minghong Xu, et al.. (2024). Threonine modulates the STAT3-SCD1 pathway to reduce fatty acid metabolism in duck hepatocytes. Poultry Science. 103(12). 104444–104444.

7.

Tu, Zewei, Yuyang Huang, Shigang Lv, et al.. (2023). Pan-cancer analysis: predictive role of TAP1 in cancer prognosis and response to immunotherapy. BMC Cancer. 23(1). 133–133. 15 indexed citations

8.

Wang, Jinchao, Guangchuan Wang, Wanli Jiang, et al.. (2023). Hepatocyte-derived exosomes deliver H2AFJ to hepatic stellate cells and promote liver fibrosis via the MAPK/STMN1 axis activation. International Immunopharmacology. 115. 109605–109605. 9 indexed citations

9.

Wu, Lei, Yuan‐Tong Liu, Wei‐Wei Deng, et al.. (2023). OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC. International Journal of Molecular Sciences. 24(16). 12904–12904. 9 indexed citations

10.

Chen, Yu, Yanquan Xu, Huakan Zhao, et al.. (2023). Myeloid-derived suppressor cells deficient in cholesterol biosynthesis promote tumor immune evasion. Cancer Letters. 564. 216208–216208. 15 indexed citations

11.

Wu, Lei, et al.. (2023). Evaluation of three fluorochromes as in situ growth markers in Manila clam Ruditapes philippinarum. Aquaculture Reports. 28. 101463–101463. 1 indexed citations

12.

Tu, Zewei, Xiaolin Wang, Huan Cai, et al.. (2023). The cell senescence regulator p16 is a promising cancer prognostic and immune check-point inhibitor (ICI) therapy biomarker. Aging. 15(6). 2136–2157. 5 indexed citations

13.

Tu, Zewei, Jingying Li, Xiaoyan Long, et al.. (2022). Transcriptional Patterns of Lower‐Grade Glioma Patients with Distinct Ferroptosis Levels, Immunotherapy Response, and Temozolomide Sensitivity. Oxidative Medicine and Cellular Longevity. 2022(1). 9408886–9408886. 7 indexed citations

14.

Wu, Lei, et al.. (2021). USP1 Promotes GC Metastasis via Stabilizing ID2. Disease Markers. 2021. 1–10. 12 indexed citations

15.

Kuang, Jingyu, Min Lu, Chuanyang Liu, et al.. (2020). RNF8 Promotes Epithelial–Mesenchymal Transition in Lung Cancer Cells via Stabilization of Slug. Molecular Cancer Research. 18(11). 1638–1649. 19 indexed citations

16.

Wang, Hui, et al.. (2020). Molecular mechanisms of MCM3AP-AS1 targeted the regulation of miR-708-5p on cell proliferation and apoptosis in gastric cancer cells. SHILAP Revista de lepidopterología. 9 indexed citations

17.

Lv, Xing, Shunyu Xiang, Xiangchuan Wang, et al.. (2020). Synthetic chloroinconazide compound exhibits highly efficient antiviral activity against tobacco mosaic virus. Pest Management Science. 76(11). 3636–3648. 39 indexed citations

18.

Rao, Lang, Lei Wu, Zhida Liu, et al.. (2020). Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis. Nature Communications. 11(1). 4909–4909. 307 indexed citations breakdown →

19.

Wu, Lei, Liang Mao, Jianfeng Liu, et al.. (2019). Blockade of TIGIT/CD155 Signaling Reverses T-cell Exhaustion and Enhances Antitumor Capability in Head and Neck Squamous Cell Carcinoma. Cancer Immunology Research. 7(10). 1700–1713. 164 indexed citations

20.

Wu, Lei & Lixian Zhong. (2018). Budget impact analysis of niraparib and olaparib for maintenance treatment of platinum-sensitive, recurrent ovarian cancer in the US. Journal of Medical Economics. 22(2). 187–195. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact